TABLE 1.
Clinicopathological characteristics | Number of samples |
||
Training cohort (n = 350) | Internal validation cohort (n = 148) | External validation cohort (n = 223) | |
INSS stage | |||
No-4 | 220 | 95 | 134 |
4 | 130 | 53 | 89 |
Age | |||
≥18 months | 140 | 58 | 120 |
<18 months | 210 | 90 | 103 |
MYCN status | |||
Not Amplified | 287 | 114 | 176 |
Amplified | 58 | 34 | 46 |
NA | 5 | 0 | 1 |
Progression | |||
Yes | 136 | 47 | 89 |
No | 214 | 101 | 134 |